

Author: Lemmens-Gruber R.
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.10, Iss.5, 2000-05, pp. : 533-548
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Patent focus on antiviral agents: June - November 2000
Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 2, 2001-02 ,pp. :





